Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEV.L Regulatory News (DEV)

  • There is currently no data for DEV

GM Statement

20 Jan 2020 12:00

RNS Number : 3391A
Dev Clever Holdings PLC
20 January 2020
 

THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014

NOT FOR PUBLICATION OR RELEASE IN OR INTO THE UNITED STATES OR AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA, OR ANY PROVINCE OR TERRITORY THEREOF OR TO OR FOR THE ACCOUNT OF ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES OR ANY PERSON RESIDENT IN AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA.

20 January 2020

 

Dev Clever Holdings plc

("Company")

Result of General Meeting, Completion of the Placing and Convertible Loan Notes

Dev Clever Holdings plc (DEV) a leading developer of consumer engagement solutions and career development platforms, is pleased to announce that all resolutions put to shareholders at the Company's General Meeting held earlier today have been passed. As a result, the 43,785,107 new ordinary shares of 1p each in the Company being issued pursuant to the placing of shares announced on 20 December 2019 ("Placing") are expected to be admitted to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange tomorrow, 21 January 2020 ("Admission"), to complete the Placing. 

On Admission, the Company will have 432,186,843 ordinary shares of 1p each in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of ordinary shares and voting rights is 432,186,843.

The above figure of 432,186,843 may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In addition, the Company announces that its controlling shareholder, Christopher Jeffries, has agreed to sell 50,000,000 ordinary shares of 1p each that he holds in the capital of the Company to third party purchasers procured by its broker, Novum Securities Limited, at 1p per share ("Sale"). On completion of the Sale, Christopher Jeffries will hold 200,000,000 ordinary shares of the Company, representing 46.28 per cent of the Company's issued share capital.

Christopher Jeffries and the Company have entered into a convertible loan note, pursuant to which the net proceeds of the Sale, amounting to £400,000 (after tax, costs and commission), will be provided to the Company as subscription amount for convertible loan notes ("Notes"). The Notes will be convertible into ordinary shares of 1p each in the capital of the Company at Christopher Jeffries' option, at any time, subject to, among other things, the Company not being required to publish a prospectus in connection with the issue of shares on conversion of the Notes and no obligations under Rule 9 of the City Code on Takeovers and Mergers being triggered by such issue of shares. Unless previously repaid or converted, the Notes will be redeemed at par by the Company on the fifth anniversary of the convertible loan note. The Notes will bear a zero coupon.

The subscription amount is intended to be used by the Company to provide additional working capital to support the marketing and roll out of its Launchpad careers platform and accompanying VICTAR virtual reality careers experience across the UK and for the adaptation of the platform for the North American market. It is expected that both Launchpad and VICTAR will be launched in the North American market, starting in the USA, from April 2020.

 

ENQUIRIES:

Dev Clever Holdings plc 

 

Christopher JeffriesChief Executive Officer and Executive ChairmanNicholas YdlibiFinance Director 

+44 (0) 845 459 0774 

+44 (0) 330 058 2922 

 

 

Novum Securities Limited - Joint BrokerColin Rowbury 

 

 

+44 (0) 20 7399 9400

 

Pello Capital - Joint Broker

Daniel Gee

 

 

 

+44 (0) 203 700 2534

 

 

- ANNOUNCEMENT ENDS -

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
GMSUROARRNUAUAR
Date   Source Headline
17th Jan 20233:45 pmRNSCancellation of Listing
16th Dec 20227:00 amRNSStatement re Cancellation of Listing and Rebrand
2nd Nov 202212:00 pmRNSTotal Voting Rights
14th Oct 20222:16 pmRNSHolding(s) in Company
14th Oct 20222:15 pmRNSHolding(s) in Company
14th Oct 20222:00 pmRNSExercise of share options and PDMR shareholding
21st Sep 20227:00 amRNSLaunch of Career Success Membership Program
15th Sep 20227:00 amRNSBoard appointment
14th Sep 20223:15 pmRNSResult of Annual General Meeting
31st Aug 202212:30 pmRNSHalf-year Report
31st Aug 20227:00 amRNSBrand Ambassador
22nd Aug 20227:15 amRNSFunding Facility
22nd Aug 20227:00 amRNSAnnual Financial Report
10th Aug 20224:15 pmRNSHolding(s) in Company
3rd Aug 20223:45 pmRNSHolding(s) in Company
2nd Aug 20227:00 amRNSTotal Voting Rights
21st Jul 20229:30 amRNSHolding(s) in Company
20th Jul 20223:00 pmRNSHolding(s) in Company
19th Jul 20223:15 pmRNSHolding(s) in Company
19th Jul 202212:15 pmRNSVeative Acquisition, Trading and Board Updates
19th Jul 202211:45 amRNSAldebaron Partnership Update and Notice of Results
17th May 20224:00 pmRNSDirectorate Change and Notice of Results
28th Apr 20222:50 pmRNSNotice of Final Results Publication
24th Feb 20227:00 amRNSAppointment of Joint Broker
24th Dec 20217:50 amRNSUpdate on Veative acquisition and suspension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSContract
6th Dec 20214:30 pmRNSSenior management appointment
29th Nov 20217:00 amRNSTrading Statement
15th Nov 20217:00 amRNSAppointment
28th Oct 20217:00 amRNSUpdate on Veative Acquisition
18th Oct 20217:00 amRNSCommon Service Centre Update
30th Sep 20217:00 amRNSUpdate on agreement with Veative
2nd Sep 20217:00 amRNSContract
27th Jul 20217:00 amRNSAcquisition
6th Jul 20214:41 pmRNSSecond Price Monitoring Extn
6th Jul 20214:35 pmRNSPrice Monitoring Extension
5th Jul 20217:00 amRNSHalf-year Report
29th Jun 20218:55 amRNSCommon Service Centre Pilot, India
21st Jun 20219:05 amRNSSecond Price Monitoring Extn
21st Jun 20219:00 amRNSPrice Monitoring Extension
21st Jun 20217:15 amRNSTactical partnership and major contract win
21st Jun 20217:00 amRNSProposed acquisition
9th Jun 20217:00 amRNSProgress in India
26th May 20214:40 pmRNSSecond Price Monitoring Extn
26th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20217:00 amRNSExercise of Options
11th May 20214:40 pmRNSSecond Price Monitoring Extn
11th May 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.